BIOMARKERS

Molecular Biopsy of Human Tumors

Biomarkers for Pancreatic cancer

1. TP53
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
2. CEACAM5
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
3. AKT1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
4. HRAS
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
5. CDKN2A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
6. KRAS
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
7. EGFR
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
8. MAPK1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
9. SMAD4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
10. NR4A3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
11. BCL2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
12. ERBB2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
13. Ki-67
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
14. MYC
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
15. ITK
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
16. PIK3CA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
17. MTOR
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
18. MUC1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
19. PR
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
20. MEN1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
21. ESR1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
22. APC
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
23. ER
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
24. JUN
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
25. SRC
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
26. GNAS
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
27. BRCA2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
28. ROS1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
29. AR
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
30. STAT3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
31. VHL
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
32. FBXW7
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
33. AFP
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
34. HIF1A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
35. MUC16
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
36. FGFR1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
37. CALCB
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
38. FAS
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
39. CTLA4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
40. KDR
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
41. BRCA1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
42. RB1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
43. KIT
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
44. PTEN
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
45. CgA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
46. TIMP1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
47. PTCH1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
48. MS4A1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
49. CCDC6
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
50. CXCR4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
51. CDKN1B
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
52. STK11
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
53. PRKAR1A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
54. RHOA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
55. ENO2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
56. IL2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
57. ATM
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
58. MLH1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
59. SMAD3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
60. POU5F1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
61. CDK4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
62. ABL2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
63. BRAF
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
64. CDX2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
65. NTRK1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
66. FH
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
67. SPEN
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
68. MAX
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
69. uPA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
70. SMAD2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
71. MDM2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
72. LDH
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
73. MET
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
74. RET
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
75. SDHB
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
76. FANCA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
77. LMNA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
78. RAF1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
79. MSH2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
80. hCG
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
81. SERPINE1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
82. BRD4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
83. HSP90AA1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
84. PRF1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
85. ABCG2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
86. MAP2K1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
87. TG
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
88. PTPRC
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
89. ERBB3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
90. DDIT3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
91. NRAS
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
92. ABL1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
93. SMO
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
94. PALB2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
95. PSA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
96. FUS
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
97. SDHA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
98. EZH2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
99. NOTCH1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
100. RAC1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
101. ARID1B
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
102. CALR
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
103. TERT
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
104. TSC1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
105. CD79A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
106. FOXP3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
107. NFE2L2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
108. AKT2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
109. BCR
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
110. NKX2-1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
111. SOX2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
112. TRIM27
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
113. CUX1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
114. RHOH
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
115. PIM1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
116. PDCD1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
117. CDK6
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
118. JAK2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
119. PDGFRB
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
120. CHEK2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
121. EP300
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
122. CD274
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
123. GOPC
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
124. MSH6
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
125. TP63
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
126. ATRX
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
127. DAXX
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
128. MYCN
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
129. POLE
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
130. TSC2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
131. CCND1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
132. CTNNB1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
133. PTPN11
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
134. MDM4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
135. WT1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
136. FHIT
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
137. CDH1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
138. ALK
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
139. BLM
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
140. KLF4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
141. HMGA2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
142. MAP2K4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
143. NF2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
144. HLA-A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
145. NDRG1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
146. REL
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
147. CASP8
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
148. FOXO1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
149. NCKIPSD
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
150. RNF43
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
151. SMARCB1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
152. YWHAE
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
153. CDKN2C
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
154. IDH1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
155. PAX8
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
156. SBDS
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
157. CLIP1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
158. ERCC2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
159. FGFR2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
160. FGFR3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
161. FLT4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
162. PMS2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
163. SDHD
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
164. TGFBR2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
165. HER1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
166. CREBBP
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
167. MYB
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
168. Beta-hCG
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
169. FOXO3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
170. HMGA1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
171. RARA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
172. SMARCA4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
173. TRA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
174. ARID1A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
175. BIRC3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
176. HOXD13
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
177. MAP3K1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
178. NF1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
179. STIL
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
180. ATR
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
181. BAP1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
182. CBL
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
183. CDH11
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
184. HNF1A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
185. KMT2A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
186. PDGFRA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
187. XPO1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
188. AXIN1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
189. ERBB4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
190. FANCC
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
191. FANCD2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
192. FLT3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
193. IDH2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
194. IL6ST
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
195. NT5C2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
196. PDGFB
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
197. STAT5B
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
198. Neurokinin
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
199. EWSR1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
200. GATA3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
201. HEY1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
202. MAP2K2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
203. MYD88
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
204. NBN
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
205. PPFIBP1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
206. SDHC
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
207. TFRC
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
208. U2AF1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
209. XPA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
210. CYLD
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
211. JAK1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
212. KEAP1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
213. NOTCH2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
214. PCSK7
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
215. SOCS1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
216. BCL10
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
217. DNMT3A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
218. ELN
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
219. FANCG
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
220. KLK2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
221. MALAT1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
222. NPM1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
223. NRG1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
224. WAS
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
225. CARS
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
226. CIITA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
227. EPAS1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
228. KMT2C
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
229. MAF
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
230. MITF
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
231. MNX1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
232. RALGDS
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
233. ALDH2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
234. ARNT
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
235. CD74
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
236. CIC
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
237. DICER1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
238. ELF4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
239. FGFR4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
240. FOXA1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
241. GPC3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
242. KLF6
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
243. NUTM1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
244. PBRM1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
245. SF3B1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
246. SUFU
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
247. TAL1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
248. TBX3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
249. TCF7L2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
250. WRN
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
251. CCND2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
252. CCNE1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
253. DROSHA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
254. EBF1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
255. ETV4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
256. ETV5
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
257. KDM6A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
258. PPM1D
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
259. PRCC
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
260. PTPN13
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
261. RPL10
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
262. SALL4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
263. SND1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
264. WIF1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
265. ZNF331
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
266. WFDC2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
267. DNM2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
268. ERCC4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
269. ERG
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
270. KMT2D
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
271. LIFR
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
272. MUTYH
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
273. NFATC2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
274. PER1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
275. PIK3R1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
276. PRDM1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
277. PTK6
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
278. SPECC1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
279. SSX2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
280. TCF3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
281. TNFRSF17
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
282. ZNF198
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
283. TOP2A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
284. ACVR1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
285. ACVR2A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
286. ARID2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
287. AXIN2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
288. B2M
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
289. BCL9
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
290. BUB1B
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
291. CDC73
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
292. CNBP
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
293. DDX5
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
294. ETV6
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
295. EXT1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
296. FAT1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
297. FEV
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
298. FOXP1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
299. HERPUD1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
300. HNRNPA2B1
    [